RANKEN JORDAN — History
CCN 263303 | 3-year financial timeline | COVID resilience: 72/100
🛡️ Public data only — no PHI permitted on this instance.
$67M
Latest Revenue (FY2022)
+12.7%
Revenue CAGR (3yr)
22.2%
Financial Timeline
| Metric | FY2020 | FY2021 | FY2022 | YoY (Latest) | CAGR |
|---|---|---|---|---|---|
| Net Patient Revenue | $53M | — | $67M | +nan% | +12.7% |
| Operating Expenses | $43M | — | $52M | +nan% | +10.4% |
| Operating Margin | 18.9% | 0.0% | 22.2% | — | +8.4% |
| Net Income | $10M | — | $15M | +nan% | +22.2% |
| Licensed Beds | 60 | nan | 60 | +nan% | +0.0% |
| Total Patient Days | 16,390 | nan | 17,492 | +nan% | +3.3% |
| Medicare Day % | nan% | nan% | 0% | +nan% | +nan% |
| Medicaid Day % | 29% | nan% | 27% | +nan% | -4.7% |
COVID Impact & Recovery
Resilience Score: 72/100 — Moderate — some COVID impact but recovering
Revenue recovery from FY2020 to FY2022: +27.1% ($53M → $67M)
FY2020 captured the initial COVID shock. Strong recovery indicates operational resilience and payer diversification.
Trend Summary
Revenue▲ Growing
Operating Margin▲ Growing
Beds▶ Stable
Medicare Mix▼ Declining
vs State Average ()
Revenue Growth
+12.7%
This Hospital
+7.6%
State Avg
Latest Margin
22.2%
This Hospital
-4.6%
State Avg
Projections (FY2023-2025)
Extrapolated from 3-year trend using linear projection. Does not account for regulatory or market changes.
| Year | Revenue (proj) | Margin (proj) |
|---|---|---|
| FY2023 (proj) | — | 25.5% |
| FY2024 (proj) | — | 28.8% |
| FY2025 (proj) | — | 32.1% |